Massachusetts Financial Services Portfolio holdings
Massachusetts Financial Services (MFS), founded in 1924 and headquartered in Boston, Massachusetts, is a pioneering investment management firm credited with launching the first U.S. mutual fund, the Massachusetts Investors Trust. Managing hundreds of billions in assets, MFS offers a wide range of actively managed investment products, including equity, fixed-income, and balanced funds, serving institutional investors, financial advisors, and individuals globally. Known for its disciplined, research-driven approach, the firm emphasizes long-term value creation through fundamental analysis and a collaborative team structure, avoiding short-term market trends. With a legacy of innovation and a strong global presence, MFS remains a respected name in the asset management industry, balancing tradition with a focus on sustainable, client-centric investing.
Top Buys
| 1 |
Exxon Mobil
XOM
|
$1.63B |
| 2 |
Qualcomm
QCOM
|
$607M |
| 3 |
GE Aerospace
GE
|
$580M |
| 4 |
Salesforce
CRM
|
$494M |
| 5 |
Chevron
CVX
|
$477M |
Top Sells
| 1 |
PXD
Pioneer Natural Resource Co.
PXD
|
$1.69B |
| 2 |
Comcast
CMCSA
|
$1.26B |
| 3 |
Boston Scientific
BSX
|
$1.14B |
| 4 |
NVIDIA
NVDA
|
$1.03B |
| 5 |
Flutter Entertainment
FLUT
|
$828M |
Sector Composition
| 1 | Technology | 23.99% |
| 2 | Financials | 18.51% |
| 3 | Healthcare | 12.55% |
| 4 | Industrials | 12.28% |
| 5 | Consumer Discretionary | 6.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
801
Bath & Body Works
BBWI
$6.62B
| $950K | ﹤0.01% |
24,340
| – | – |
|
802
Arcturus Therapeutics
ARCT
$443M
| $931K | ﹤0.01% |
38,229
-2,897
| -7% | -$70.5K |
|
803
Rimini Street
RMNI
$401M
| $926K | ﹤0.01% |
301,607
+10,105
| +3% | +$31K |
|
804
Arcus Biosciences
RCUS
$1.22B
| $886K | ﹤0.01% |
58,173
+1,951
| +3% | +$29.7K |
|
805
Lyell Immunopharma
LYEL
$217M
| $837K | ﹤0.01% |
28,866
-48,176
| -63% | -$1.4M |
|
806
iShares Russell 1000 Growth ETF
IWF
$117B
| $818K | ﹤0.01% |
+2,245
| New | +$818K |
|
807
Commercial Metals
CMC
$6.45B
| $801K | ﹤0.01% |
14,566
+1,340
| +10% | +$73.7K |
|
808
Fox Factory Holding Corp
FOXF
$1.19B
| $787K | ﹤0.01% |
16,338
+549
| +3% | +$26.5K |
|
809
Lockheed Martin
LMT
$106B
| $777K | ﹤0.01% |
1,664
| – | – |
|
810
Organogenesis Holdings
ORGO
$643M
| $755K | ﹤0.01% |
269,741
+9,054
| +3% | +$25.4K |
|
811
BioAtla
BCAB
$28.2M
| $741K | ﹤0.01% |
541,199
+14,737
| +3% | +$20.2K |
|
812
Leslie's
LESL
$60.5M
| $718K | ﹤0.01% |
+171,466
| New | +$718K |
|
813
Zymeworks
ZYME
$1.07B
| $696K | ﹤0.01% |
+81,789
| New | +$696K |
|
814
Owens Corning
OC
$12.6B
| $696K | ﹤0.01% |
4,006
+61
| +2% | +$10.6K |
|
815
Ironwood Pharmaceuticals
IRWD
$179M
| $664K | ﹤0.01% |
101,879
+3,419
| +3% | +$22.3K |
|
816
Cardlytics
CDLX
$49.1M
| $661K | ﹤0.01% |
80,546
+2,702
| +3% | +$22.2K |
|
817
M/I Homes
MHO
$4.04B
| $658K | ﹤0.01% |
5,384
+369
| +7% | +$45.1K |
|
818
Constellium
CSTM
$1.91B
| $649K | ﹤0.01% |
34,422
+3,163
| +10% | +$59.6K |
|
819
Royal Gold
RGLD
$11.9B
| $640K | ﹤0.01% |
5,114
+471
| +10% | +$59K |
|
820
Teladoc Health
TDOC
$1.36B
| $627K | ﹤0.01% |
64,132
+2,153
| +3% | +$21.1K |
|
821
Teradata
TDC
$1.94B
| $615K | ﹤0.01% |
17,798
+1,637
| +10% | +$56.6K |
|
822
The Mosaic Company
MOS
$10.3B
| $605K | ﹤0.01% |
20,924
| – | – |
|
823
Hope Bancorp
HOPE
$1.43B
| $587K | ﹤0.01% |
+54,629
| New | +$587K |
|
824
Fate Therapeutics
FATE
$111M
| $548K | ﹤0.01% |
167,055
+5,605
| +3% | +$18.4K |
|
825
Alector
ALEC
$286M
| $513K | ﹤0.01% |
112,920
+3,790
| +3% | +$17.2K |
|